A new database, designed to facilitate the exchange of information on compliance with Good Manufacturing Practice within the European network - called EudraGMP - has been introduced by the European Medicines Agency (EMEA). The Agency claims this will enhance the ability of national competent authorities in Europe to supervise the quality of medicines.
EudraGMP contains information on all manufacturing and importation authorizations issued by national competent authorities within the network, ie, the European Union's member states plus Iceland, Liechtenstein and Norway, and will contain data on GMP certifications. With around 15,000 importers and manufacturers in the countries concerned, the EMEA says it is expected that data from up to 7,000 new GMP certificates will be included in the database each year.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze